Screener
Orchestra BioMed Holdings, Inc. OBIO Q4 2025 Annual earnings
Reported March 12, 2026 · Before market open
Revenue$30.9MBeat by $30.0M
EPS$0.26Beat by $0.64
Revenue estimate$931.0K
EPS estimate-$0.38
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$128.0K
EPS estimate-$0.40
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Orchestra BioMed Holdings, Inc. report Q4 2025 earnings?
- Orchestra BioMed Holdings, Inc. (OBIO) reported Q4 2025 earnings on March 12, 2026 before market open.
- What were Orchestra BioMed Holdings, Inc.'s Q4 2025 revenue and EPS?
- Orchestra BioMed Holdings, Inc. reported revenue of $30.9M and eps of $0.26 for Q4 2025.
- Did Orchestra BioMed Holdings, Inc. beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $931.0K by $30.0M. EPS beat the consensus estimate of $-0.38 by $0.64.
- How did Orchestra BioMed Holdings, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 12120.2% from $253.0K a year earlier.
- Where can I find Orchestra BioMed Holdings, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001104659-26-026754) directly on SEC EDGAR. The filing index links above go to sec.gov.
